Forged out of the knowledge from decades of cancer and immunology research, Immunotherapy is emerging as an effective therapy against cancer. Saman Maleki profiles the recent development of a new immunotherapy drug, Ipilimumab, which disables one of cancer’s defences against immune cell attack.
Cancer Immunotherapy a late sucess story. Published in The Londoner (August 21th, page 10).
Saman Maleki holds a PhD in Cancer Immunology from Western University.
Part of the monthly series “Promise and Progress in Research” co-ordinated by the Canadian Cancer Society Volunteer Research Information Outreach Team (RIOT), London and published in The Londoner.